On October 15, 2021 Alligator Bioscience reported that it will host a conference call (in English) investors, analysts and media on Thursday, October 21st, 2021, at 14:00 CET (Press release, Alligator Bioscience, OCT 15, 2021, View Source [SID1234591275]). Alligator will publish the company’s interim report on Thursday, October 21, 2021, at 8:00 CET.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

CEO, Søren Bregenholt and CFO, Marie Svensson will present the interim report for the period January – September 2021 Report followed by a Q&A session.